Teaching oncology pharmacotherapy: focus on cancer as a chronic disease

ObjectiveTo examine how United States schools and colleges of pharmacy address oncology pharmacotherapy and provide guidance for change based on current practice needs.MethodsA survey of pharmacy practice department chairs at schools and colleges of pharmacy in the U.S. was conducted using a 20-question survey instrument. The instrument captured oncology teaching methods; oncology pathophysiology; pharmacotherapy contact hours, education, and background of instructors; and personal opinions regarding the importance of oncology in the professional pharmacy curriculum.ResultsSeventy-two (62%) of the 116 institutions responded. A median of 28 contact hours were reported for oncology pharmacotherapy (range 8–108). Two-thirds of respondents reporting below 28 contact hours expressed no need to dedicate more time to oncology pharmacotherapy. About 60% of schools use board-certified oncology specialists, but about 20% use faculty without oncology credentials.ConclusionsThese survey results may provide guidance to schools and colleges of pharmacy to help ensure that all pharmacists have sufficient training in oncology to provide competent care to patients with cancer.